“[Clinical and economic evaluation of the introduction of the combinazion trametinib + dabrafenib in the management of advanced melanoma in the Italian market]” (2016) Farmeconomia. Health economics and therapeutic pathways, 17(3S), pp. 1–32. doi:10.7175/fe.v17i3S.1279.